Boston Trust Walden Corp - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.

Quarter-by-quarter ownership
Boston Trust Walden Corp ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$205,248
+0.9%
2,0150.0%0.00%0.0%
Q2 2023$203,334
-94.7%
2,015
-95.8%
0.00%
-96.6%
Q1 2018$3,846,000
-6.4%
47,560
-2.9%
0.06%
-3.3%
Q4 2017$4,111,000
+6.0%
48,960
+8.4%
0.06%0.0%
Q3 2017$3,877,000
+2.9%
45,1600.0%0.06%
-1.6%
Q2 2017$3,769,000
+15.4%
45,160
+2.7%
0.06%
+19.6%
Q1 2017$3,265,000
-47.0%
43,960
-48.1%
0.05%
+4.1%
Q4 2016$6,166,000
+84.6%
84,670
+100.1%
0.05%
-10.9%
Q3 2016$3,341,000
+1.6%
42,310
+6.1%
0.06%
-1.8%
Q2 2016$3,289,000
+12.4%
39,860
-1.3%
0.06%
+9.8%
Q1 2016$2,926,000
-15.7%
40,385
+0.1%
0.05%
-20.3%
Q4 2015$3,470,000
-9.6%
40,335
-3.4%
0.06%0.0%
Q3 2015$3,838,000
-12.0%
41,760
-5.9%
0.06%
-4.5%
Q2 2015$4,363,000
-9.7%
44,360
-9.5%
0.07%
-6.9%
Q1 2015$4,832,000
+5.8%
49,010
-0.6%
0.07%
+5.9%
Q4 2014$4,569,000
+0.9%
49,310
+2.5%
0.07%
-2.9%
Q3 2014$4,529,000
+4.1%
48,110
+0.1%
0.07%
+11.1%
Q2 2014$4,350,000
+61.7%
48,060
+51.9%
0.06%
+57.5%
Q1 2014$2,690,000
+4.3%
31,635
-1.4%
0.04%
+5.3%
Q4 2013$2,579,000
+11.7%
32,081
+6.6%
0.04%
+8.6%
Q3 2013$2,308,000
+635.0%
30,085
+577.3%
0.04%
+600.0%
Q2 2013$314,0004,4420.01%
Other shareholders
NOVARTIS A G shareholders Q2 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders